Factor-inhibiting HIF (FIH) promotes lung cancer progression
Factor-inhibiting HIF (FIH) is an asparagine hydroxylase that acts on hypoxia-inducible factors (HIFs) to control cellular adaptation to hypoxia. FIH is expressed in several tumor types, but its impact in tumor progression remains largely unexplored. We observed that FIH was expressed on human lung...
Guardat en:
| Autors principals: | , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Clinical investigation
2023-10-01
|
| Col·lecció: | JCI Insight |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1172/jci.insight.167394 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
